A Phase I and Dose Expansion Cohort Study of Panobinostat in Combination With Fludarabine and Cytarabine in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase of Trial: Phase I/II
Latest Information Update: 10 Jun 2017
At a glance
- Drugs Panobinostat (Primary) ; Cytarabine; Fludarabine; Folinic acid; Folinic acid
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- 06 Apr 2017 Planned End Date changed from 1 Apr 2018 to 31 Aug 2018.
- 06 Apr 2017 Planned primary completion date changed from 1 Apr 2018 to 31 Aug 2018.
- 15 Feb 2016 New trial record